Identification of Two Glioblastoma-associated Stromal Cell Subtypes with Different Carcinogenic Properties in Histologically Normal Surgical Margins

Overview

Journal J Neurooncol

Publisher Springer

Date 2014 Dec 16

PMID 25503303

Citations 16

Authors

Anne Clavreul

Amandine Etcheverry

Clement Tetaud

Audrey Rousseau

Tony Avril

Cecile Henry

Jean Mosser

Philippe Menei

Affiliations

Soon will be listed here.

Abstract

Glioblastoma (GB) is a highly infiltrative tumor recurring within a few centimeters of the resection cavity in 85 % of cases, even in cases of complete tumor resection and adjuvant chemo/radiotherapy. We recently isolated GB-associated stromal cells (GASCs) from the GB peritumoral zone, with phenotypic and functional properties similar to those of the cancer-associated fibroblasts present in the stroma of carcinomas. In particular, GASCs promote blood vessel development and have tumor-promoting effects on glioma cells in vitro and in vivo. In this study, we characterized these cells further, by analyzing the transcriptome and methylome of 14 GASC and five control stromal cell preparations derived from non-GB peripheral brain tissues. We identified two subtypes of GASCs in surgical margins in GB patients: GASC-A and GASC-B. GASC-B promoted the development of tumors and endothelium, whereas GASC-A did not. A difference in DNA methylation may underlie these two subtypes. We identified various proteins as being produced in the procarcinogenic GASC-B. Some of these proteins may serve as prognostic factors for GB and/or targets for anti-glioma treatment. In conclusion, in this era of personalized therapy, the status of GASCs in GB-free surgical margins should be taken into account, to improve treatment and the prevention of recurrence.

Citing Articles

Exosomal TNF-α mediates voltage-gated Na+ channel 1.6 overexpression and contributes to brain tumor-induced neuronal hyperexcitability.

Sanchez Trivino C, Spelat R, Spada F, dAngelo C, Manini I, Rolle I J Clin Invest. 2024; 134(18).

PMID: 39088270 PMC: 11405049. DOI: 10.1172/JCI166271.

Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.

Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y J Hematol Oncol. 2024; 17(1):31.

PMID: 38720342 PMC: 11077829. DOI: 10.1186/s13045-024-01544-7.

Glioblastoma-Associated Mesenchymal Stem/Stromal Cells and Cancer-Associated Fibroblasts: Partners in Crime?.

Lootens T, Roman B, Stevens C, de Wever O, Raedt R Int J Mol Sci. 2024; 25(4).

PMID: 38396962 PMC: 10889514. DOI: 10.3390/ijms25042285.

Current Knowledge about the Peritumoral Microenvironment in Glioblastoma.

Trevisi G, Mangiola A Cancers (Basel). 2023; 15(22).

PMID: 38001721 PMC: 10670229. DOI: 10.3390/cancers15225460.

The peritumoral brain zone in glioblastoma: where we are and where we are going.

Giambra M, Di Cristofori A, Valtorta S, Manfrellotti R, Bigiogera V, Basso G J Neurosci Res. 2022; 101(2):199-216.

PMID: 36300592 PMC: 10091804. DOI: 10.1002/jnr.25134.

References

Stupp R, Hegi M, Mason W, van den Bent M, Taphoorn M, Janzer R . Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009; 10(5):459-66. DOI: 10.1016/S1470-2045(09)70025-7. View

De Bonis P, Anile C, Pompucci A, Fiorentino A, Balducci M, Chiesa S . The influence of surgery on recurrence pattern of glioblastoma. Clin Neurol Neurosurg. 2012; 115(1):37-43. DOI: 10.1016/j.clineuro.2012.04.005. View

Polanska U, Orimo A . Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells. J Cell Physiol. 2013; 228(8):1651-7. DOI: 10.1002/jcp.24347. View

Hu M, Yao J, Cai L, Bachman K, van den Brule F, Velculescu V . Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet. 2005; 37(8):899-905. DOI: 10.1038/ng1596. View

Dahlrot R, Hermansen S, Hansen S, Kristensen B . What is the clinical value of cancer stem cell markers in gliomas?. Int J Clin Exp Pathol. 2013; 6(3):334-48. PMC: 3563206. View

Wang Z, Yan X . CD146, a multi-functional molecule beyond adhesion. Cancer Lett. 2012; 330(2):150-62. DOI: 10.1016/j.canlet.2012.11.049. View

Jiang L, Gonda T, Gamble M, Salas M, Seshan V, Tu S . Global hypomethylation of genomic DNA in cancer-associated myofibroblasts. Cancer Res. 2008; 68(23):9900-8. PMC: 2670548. DOI: 10.1158/0008-5472.CAN-08-1319. View

Hu B, Phan S . Myofibroblasts. Curr Opin Rheumatol. 2012; 25(1):71-7. PMC: 4007118. DOI: 10.1097/BOR.0b013e32835b1352. View

Sica G, Lama G, Anile C, Geloso M, La Torre G, De Bonis P . Assessment of angiogenesis by CD105 and nestin expression in peritumor tissue of glioblastoma. Int J Oncol. 2010; 38(1):41-9. View

10.

Clavreul A, Guette C, Faguer R, Tetaud C, Boissard A, Lemaire L . Glioblastoma-associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties. J Pathol. 2014; 233(1):74-88. DOI: 10.1002/path.4332. View

11.

Stummer W, Pichlmeier U, Meinel T, Wiestler O, Zanella F, Reulen H . Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006; 7(5):392-401. DOI: 10.1016/S1470-2045(06)70665-9. View

12.

Pirotte B, Levivier M, Goldman S, Massager N, Wikler D, Dewitte O . Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients. Neurosurgery. 2009; 64(3):471-81. DOI: 10.1227/01.NEU.0000338949.94496.85. View

13.

Mangiola A, Lama G, Giannitelli C, De Bonis P, Anile C, Lauriola L . Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications. Clin Cancer Res. 2007; 13(23):6970-7. DOI: 10.1158/1078-0432.CCR-07-1229. View

14.

Abdelzaher E, El-Gendi S, Yehya A, Gowil A . Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression. Br J Neurosurg. 2010; 25(6):707-13. DOI: 10.3109/02688697.2010.522743. View

15.

Clavreul A, Jean I, Preisser L, Chassevent A, Sapin A, Michalak S . Human glioma cell culture: two FCS-free media could be recommended for clinical use in immunotherapy. In Vitro Cell Dev Biol Anim. 2009; 45(9):500-11. DOI: 10.1007/s11626-009-9215-4. View

16.

Matsuda Y, Hagio M, Ishiwata T . Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis. World J Gastroenterol. 2013; 19(1):42-8. PMC: 3545228. DOI: 10.3748/wjg.v19.i1.42. View

17.

Aldave G, Tejada S, Pay E, Marigil M, Bejarano B, Idoate M . Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery. Neurosurgery. 2013; 72(6):915-20. DOI: 10.1227/NEU.0b013e31828c3974. View

18.

Hatanpaa K, Hu T, Vemireddy V, Foong C, Raisanen J, Oliver D . High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas. J Neurooncol. 2014; 117(1):183-189. PMC: 4326086. DOI: 10.1007/s11060-014-1376-7. View

19.

Al-Rakan M, Colak D, Hendrayani S, Al-Bakheet A, Al-Mohanna F, Kaya N . Breast stromal fibroblasts from histologically normal surgical margins are pro-carcinogenic. J Pathol. 2013; 231(4):457-65. PMC: 4284036. DOI: 10.1002/path.4256. View

20.

Montero A, Diaz-Montero C, Mao L, Youssef E, Estecio M, Shen L . Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer. Cancer Biol Ther. 2007; 5(11):1494-501. DOI: 10.4161/cbt.5.11.3299. View